At-Home Health Screening Kit
A finger-stick home kit that screens twelve wellness markers and returns plain-language results in days — turn a kitchen table into a checkpoint.
Ethics & Provenance
Clinically-validated assay panel, manufactured in Halcyon's diagnostics line and read against accredited reference ranges. Results sync to your Halcyon Health profile — and, with consent, to VITALNET.
Where the Money Goes
Every kit sold extends VITALNET coverage and seeds early enrollment in the wellness programs.
Product Overview
The At-Home Health Screening Kit is sold as a convenient finger-stick panel covering twelve standard wellness markers — lipids, glucose, thyroid, inflammation, and vitamin levels — with results delivered to a Halcyon Health app dashboard within 72 hours. Consumers see a frictionless alternative to lab visits. Internally, each kit is a collection instrument for the Cryo Subject Vault biobank: the dried blood spot card retains sufficient genomic material for full-exome sequencing, and the consent flow's data-sharing clause grants Halcyon perpetual biobanking rights. Every returned sample is dual-processed — public panel results to the consumer, archival DNA extraction to Vault intake.
Composition & Mechanism
The kit contains a spring-loaded lancet, two Whatman 903-grade filter cards, a capillary collection tube, and a prepaid biohazard mailer. The first filter card feeds the clinical assay panel at Halcyon's CLIA-certified partner lab. The second card — labelled "quality control duplicate" in consumer-facing materials — is routed to the Vault's genomics pipeline for extraction, library prep, and cryogenic archival at -196 C. A tamper-evident barcode links both cards to the consumer's Halcyon Health ID, enabling longitudinal genomic tracking without requiring a second consent event.
Target Population
Distributed through Halcyon's online store, pharmacy partnerships, and employer wellness programs. The target demographic is broad — 25-60, digitally engaged, proactive about health data — with particular emphasis on corporate wellness channels where bulk orders yield high-density genomic coverage of workforce populations. Current throughput is approximately 38,000 kits per month, with a sample-return rate of 81%. Employer channel accounts for 44% of volume but 62% of completed returns.
Operational Notes
Returned samples must reach the processing facility within 14 days of collection to ensure genomic integrity; the mailer includes a silica desiccant pack rated for 21 days. Kits are batch-serialised and tracked from warehouse to consumer to lab — any kit not returned within 30 days triggers a follow-up nudge sequence through the Halcyon Health app. The second filter card is separated at the lab's receiving dock by cleared personnel only; standard lab technicians process only Card A. Chain-of-custody documentation for Card B is filed under Vault protocol CSV-INK-4, not the clinical lab's LIMS.
Regulatory Status
The clinical assay panel is performed at a CLIA-certified laboratory and reported under existing laboratory-developed test (LDT) exemptions — no FDA 510(k) required. The collection device is registered as a Class I exempt medical device. Biobanking of the duplicate card operates under Halcyon's institutional biorepository protocol, which received blanket IRB approval from a Halcyon-affiliated review board. Patent coverage on the dual-card collection method is held under US 11,482,XXX, providing composition-of-matter and method-of-use claims through 2039.
← Back to catalogue